Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3195)
All Articles published online
|
Apr 21, 2006 (publication date) through Jan 12, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Cianci R, Montalto M, Pandolfi F, Gasbarrini GB, Cammarota G. Third-line rescue therapy for Helicobacter pylori infection. World J Gastroenterol 2006; 12(15): 2313-2319 [PMID: 16688818 DOI: 10.3748/wjg.v12.i15.2313] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i15/2313.htm |
| Number | Citing Articles |
| 1 |
Aleksandra Radovanovic Spurnic, Zoran Bukumiric, Djordje Jevtovic, Branko Brmbolic, Tatijana Pekmezovic, Dubravka Salemovic, Ivana Pesic Pavlovic, Ivana Milosevic, Jovan Ranin, Milos Korac, Giuseppe Vittorio De Socio. Helicobacter pylori infection rates in dyspeptic Serbian HIV-infected patients compared to HIV-negative controls. PLOS ONE 2021; 16(3): e0248041 doi: 10.1371/journal.pone.0248041
|
| 2 |
Javier P. Gisbert. Review: Second-line rescue therapy of Helicobacter pylori infection. Therapeutic Advances in Gastroenterology 2009; 2(6): 331 doi: 10.1177/1756283X09347109
|
| 3 |
Vincent Cattoir, Juliette Nectoux, Christine Lascols, Lionel Deforges, Jean-Charles Delchier, Francis Megraud, Claude-James Soussy, Emmanuelle Cambau. Update on fluoroquinolone resistance in Helicobacter pylori: new mutations leading to resistance and first description of a gyrA polymorphism associated with hypersusceptibility. International Journal of Antimicrobial Agents 2007; 29(4): 389 doi: 10.1016/j.ijantimicag.2006.11.007
|
| 4 |
Jose Manuel Silvan, Alba Gutiérrez-Docio, Silvia Moreno-Fernandez, Teresa Alarcón-Cavero, Marin Prodanov, Adolfo J. Martinez-Rodriguez. Procyanidin-Rich Extract from Grape Seeds as a Putative Tool against Helicobacter pylori. Foods 2020; 9(10): 1370 doi: 10.3390/foods9101370
|
| 5 |
Zahyra Kaouah, Julien M. Buyck, Maxime Pichon, Christophe Burucoa, Laure Prouvensier, Jeremy Moreau, Sandrine Marchand, Julie Cremniter, Nicolas Grégoire. In vitro efficacy of combinations of antibiotics used in clinical practice on clinical isolates of Helicobacter pylori. Helicobacter 2024; 29(3) doi: 10.1111/hel.13081
|
| 6 |
Krit Suknuntha, Vimon Tantishaiyakul, Nimit Worakul, Wirach Taweepreda. Characterization of muco- and bioadhesive properties of chitosan, PVP, and chitosan/PVP blends and release of amoxicillin from alginate beads coated with chitosan/PVP. Drug Development and Industrial Pharmacy 2011; 37(4): 408 doi: 10.3109/03639045.2010.518149
|
| 7 |
Nastaran Farzi, Abbas Yadegar, Amir Sadeghi, Hamid Asadzadeh Aghdaei, Sinéad Marian Smith, Josette Raymond, Hidekazu Suzuki, Mohammad Reza Zali. High Prevalence of Antibiotic Resistance in Iranian Helicobacter pylori Isolates: Importance of Functional and Mutational Analysis of Resistance Genes and Virulence Genotyping. Journal of Clinical Medicine 2019; 8(11): 2004 doi: 10.3390/jcm8112004
|
| 8 |
M. Gómez-Burgaz, B. García-Ochoa, S. Torrado-Santiago. Chitosan–carboxymethylcellulose interpolymer complexes for gastric-specific delivery of clarithromycin. International Journal of Pharmaceutics 2008; 359(1-2): 135 doi: 10.1016/j.ijpharm.2008.03.042
|
| 9 |
Elżbieta Karczewska, Karolina Klesiewicz, Iwona Skiba, Izabela Wojtas-Bonior, Edward Sito, Krzysztof Czajecki, Małgorzata Zwolińska-Wcisło, Alicja Budak. Variability in Prevalence ofHelicobacter pyloriStrains Resistant to Clarithromycin and Levofloxacin in Southern Poland. Gastroenterology Research and Practice 2012; 2012: 1 doi: 10.1155/2012/418010
|
| 10 |
Lukas Hleba, Ivana Charousova, Miroslava Cisarova, Anton Kovacik, Jan Kormanec, Juraj Medo, Matej Bozik, Sona Javorekova. Rapid identification of Streptomyces tetracycline producers by MALDI-TOF mass spectrometry. Journal of Environmental Science and Health, Part A 2018; 53(12): 1083 doi: 10.1080/10934529.2018.1474581
|
| 11 |
Hyun Chul Lim, Yong Jae Lee, Byoungrak An, Seung Woo Lee, Yong Chan Lee, Byung Soo Moon. Rifabutin‐based High‐dose Proton‐pump Inhibitor and Amoxicillin Triple Regimen as the Rescue treatment for Helicobacter pylori. Helicobacter 2014; 19(6): 455 doi: 10.1111/hel.12147
|
| 12 |
Javier P Gisbert. “Rescue” regimens after <italic>Helicobacter pylori</italic> treatment failure. World Journal of Gastroenterology 2008; 14(35): 5385-5402 doi: 10.3748/wjg.14.5385
|
| 13 |
Juntaro Matsuzaki, Hidekazu Suzuki, Hitoshi Tsugawa, Toshihiro Nishizawa, Toshifumi Hibi. Homology model of the DNA gyrase enzyme of Helicobacter pylori, a target of quinolone‐based eradication therapy. Journal of Gastroenterology and Hepatology 2010; 25(s1) doi: 10.1111/j.1440-1746.2010.06245.x
|
| 14 |
Quan Zhou, Ling-Ling Zhu, Xiao-Feng Yan, Wen-Sheng Pan, Su Zeng. Drug utilization of clarithromycin for gastrointestinal disease treatment. World Journal of Gastroenterology 2008; 14(39): 6065-6071 doi: 10.3748/wjg.14.6065
|
| 15 |
Yoshihiro Hirata, Tomoya Ohmae, Ayako Yanai, Kosuke Sakitani, Yoku Hayakawa, Shuntaro Yoshida, Takafumi Sugimoto, Yuzo Mitsuno, Masao Akanuma, Yutaka Yamaji, Keiji Ogura, Shin Maeda, Kazuhiko Koike. Sitafloxacin resistance in Helicobacter pylori isolates and sitafloxacin-based triple therapy as a third-line regimen in Japan. International Journal of Antimicrobial Agents 2012; 39(4): 352 doi: 10.1016/j.ijantimicag.2011.12.002
|
| 16 |
Elżbieta Karczewska, Izabela Wojtas-Bonior, Edward Sito, Małgorzata Zwolińska-Wcisło, Alicja Budak. Primary and secondary clarithromycin, metronidazole, amoxicillin and levofloxacin resistance to Helicobacter pylori in southern Poland. Pharmacological Reports 2011; 63(3): 799 doi: 10.1016/S1734-1140(11)70592-8
|
| 17 |
Mohammad Hossein Peypar, Amin Vesal Yeganeh, Ali Ramazani, Arman Alizadeh, Mahdi Abdorrashidi, Amirmohammad Tohidinia, Mohammad Mahdi Shamlou, Mohammad Heiat. Oral immunotherapy for Helicobacter pylori: Can it be trusted? A systematic review. Helicobacter 2024; 29(2) doi: 10.1111/hel.13067
|
| 18 |
Sang Kyu Lee, Sang Woo Lee, Jae Yeon Park, Bo Sung Kwon, Seung Young Kim, Jong Jin Hyun, Jeong Han Kim, Sung Woo Jung, Ja Seol Koo, Hyung Joon Yim, Jai Hyun Choi. Effectiveness and Safety of Repeated Quadruple Therapy in Helicobacter pylori Infection After Failure of Second-line Quadruple Therapy. Helicobacter 2011; 16(5): 410 doi: 10.1111/j.1523-5378.2011.00870.x
|
| 19 |
Hafez Fakheri, Zohreh Bari, Hossein Sardarian. A modified Bismuth‐Containing Quadruple Therapy Including a Short Course of Furazolidone for Helicobacter pylori Eradication After Sequential Therapy Failure. Helicobacter 2012; 17(4): 264 doi: 10.1111/j.1523-5378.2012.00946.x
|
| 20 |
Myung Ho Jeong, Jun-Won Chung, Sang Jin Lee, Minsu Ha, Seok Hoo Jeong, Sunyoung Na, Byung Soo Na, Sung Keun Park, Yoon Jae Kim, Kwang An Kwon, Kwang Il Ko, Yunjeong Jo, Ki Baik Hahm, Hwoon-Yong Jung. Comparison of Rifabutin- and Levofloxacin-based Third-line Rescue Therapies forHelicobacter pylori. The Korean Journal of Gastroenterology 2012; 59(6): 401 doi: 10.4166/kjg.2012.59.6.401
|
| 21 |
Nuno Almeida, José M. Romãozinho, Maria M. Donato, Cristina Luxo, Olga Cardoso, Maria A. Cipriano, Carol Marinho, Carlos Sofia. Triple Therapy with High‐Dose Proton‐Pump Inhibitor, Amoxicillin, and Doxycycline Is Useless for Helicobacter pylori Eradication: A Proof‐of‐Concept Study. Helicobacter 2014; 19(2): 90 doi: 10.1111/hel.12106
|
| 22 |
Noor Safwah Damanhuri, Endang Kumolosasi, Marhanis Salihah Omar, Amirul Faiz Abd Razak, Ahmad Hasnan Mansor. The influence of P-glycoprotein expression in the standard treatment of Helicobacter pylori infection in Sprague Dawley rats. DARU Journal of Pharmaceutical Sciences 2021; 29(1): 13 doi: 10.1007/s40199-020-00377-2
|
| 23 |
Toshihiro Nishizawa, Hidekazu Suzuki, Toshifumi Hibi. Quinolone-Based Third-Line Therapy for Helicobacter pylori Eradication. Journal of Clinical Biochemistry and Nutrition 2009; 44(2): 119 doi: 10.3164/jcbn.08-220R
|
| 24 |
Mu Feng, Hilda Namanja-Magliano, Saranathan Rajagopalan, Tanmay Mishra, Rodrigo G. Ducati, Brett M. Hirsch, Libusha Kelly, Wendy Szymczak, Jorge Eduardo Fajardo, Simone Sidoli, Andras Fiser, William R. Jacobs, Vern L. Schramm. MAT Gain of Activity Mutation in Helicobacter pylori Is Associated with Resistance to MTAN Transition State Analogues. ACS Infectious Diseases 2023; 9(4): 966 doi: 10.1021/acsinfecdis.2c00644
|
| 25 |
György M Buzás, Jolán Józan. Nitrofuran‐based regimens for the eradication of Helicobacter pylori infection. Journal of Gastroenterology and Hepatology 2007; 22(10): 1571 doi: 10.1111/j.1440-1746.2007.05082.x
|